Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.60 |
| ▸ | GLP1R | P43220 | 11/20 | 0.58 |
| ▸ | SCTR | P47872 | 1/20 | 0.58 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
| ▸ | GCGR | P47871 | 1/20 | 0.54 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.54 |
| ▸ | CCKBR | P32239 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29880436 | 1.00 | CALCR (0.60) | CALCRGLP1RSCTRCRHR1CRHR2 | |
| SCHEMBL29726691 | 1.00 | CALCR (0.60) | CALCRGLP1RSCTRCRHR1CRHR2 | |
| SCHEMBL29994110 | 0.98 | CALCR (0.58) | CALCRGLP1RSCTRCRHR1CRHR2 | |
| SCHEMBL31265506 | 0.97 | CALCR (0.60) | CALCRGLP1RSCTRCRHR1CRHR2 | |
| SCHEMBL29378700 | 0.94 | CALCR (0.54) | CALCRGLP1RSCTRCRHR1CRHR2 | |
| SCHEMBL29394888 | 0.94 | GLP1R (0.58) | CALCRGLP1RSCTRGCGR | |
| SCHEMBL31139948 | 0.93 | GLP1R (0.66) | GLP1RSCTRGCGRCCKBR | |
| SCHEMBL31139979 | 0.92 | GLP1R (0.66) | GLP1RSCTRGCGR | |
| SCHEMBL30207768 | 0.92 | GLP1R (0.56) | CALCRGLP1RSCTRGCGR | |
| SCHEMBL29913342 | 0.92 | GLP1R (0.56) | CALCRGLP1RSCTRGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108118-A1 | CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD | THORNHILL THERAPEUTICS INC (US) | 2025-04-03 | — | — | US | disclosed |
| US-20240009316-A1 | CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD | THORNHILL THERAPEUTICS, INC. | 2024-01-11 | — | — | US | disclosed |